These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17357033)

  • 1. Topiramate in the treatment of highly refractory patients with Dravet syndrome.
    Kröll-Seger J; Portilla P; Dulac O; Chiron C
    Neuropediatrics; 2006 Dec; 37(6):325-9. PubMed ID: 17357033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in the treatment of severe myoclonic epilepsy in infancy.
    Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR
    Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of topiramate in eleven patients with Dravet syndrome].
    Takahashi H; Takahashi Y; Mine J; Mukaida S; Ikegami M; Ikeda H; Ohtani H; Shimomura J; Kubota Y; Fujiwara T
    No To Hattatsu; 2010 Jul; 42(4):273-6. PubMed ID: 20666132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients.
    Thijs J; Verhelst H; Van Coster R
    Acta Neurol Belg; 2001 Sep; 101(3):171-6. PubMed ID: 11817266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoclonic astatic epilepsy: an age-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution.
    Trivisano M; Specchio N; Cappelletti S; Di Ciommo V; Claps D; Specchio LM; Vigevano F; Fusco L
    Epilepsy Res; 2011 Nov; 97(1-2):133-41. PubMed ID: 21873030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration/dose ratio of topiramate during pregnancy.
    Westin AA; Nakken KO; Johannessen SI; Reimers A; Lillestølen KM; Brodtkorb E
    Epilepsia; 2009 Mar; 50(3):480-5. PubMed ID: 19178558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe polymorphic epilepsy of infancy.
    Dooley J; Camfield P; Gordon K
    J Child Neurol; 1995 Jul; 10(4):339-40. PubMed ID: 7594273
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacologic treatment of Dravet syndrome.
    Chiron C; Dulac O
    Epilepsia; 2011 Apr; 52 Suppl 2():72-5. PubMed ID: 21463285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
    Myers KA; Lightfoot P; Patil SG; Cross JH; Scheffer IE
    Dev Med Child Neurol; 2018 Jun; 60(6):574-578. PubMed ID: 29473155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.